GlaxoSmithKline
Canadians prescribed Paxil during pregnancy who allege birth defects may qualify for compensation under a court-approved national settlement.
Opening soonCanada-wideClaim deadline: Pending court decisionEstimated payout: $2,000 - $40,000Claims not open yet
About this settlement
Alleged failure to warn of birth defect risks associated with Paxil use during pregnancy.
A national class action settlement was approved relating to claims that Paxil and Paxil CR caused certain birth defects when taken during pregnancy. Compensation is distributed through a court-supervised claims and points system.
Who qualifies
- Individuals prescribed Paxil or Paxil CR in Canada
- Alleged birth defects linked to prenatal exposure
- Approved eligible claimants under court review
$2,000 - $40,000
Claim deadline: Pending court decision